Full callmevShield.submitEncrypted
MethodSubmit Encrypted
SectionMev Shield
Signer5DvfaL…yZMkiN
Nonce1,960
Fee0.000013 TAO
Tip0
Call arguments
2 parametersArg 1
0x4d6bf3a39c5a3d0b32493eb7a17505bacf8d6718aa9f5cd884a40659c2eab687
Arg 2
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